FDA seeks ways to reward quality

02/6/2013 | Pharmalot.com

The FDA is considering developing a quality scorecard for drug manufacturers in an effort to prevent quality problems that have contributed to recent drug shortages, according to an article in Clinical Pharmacology & Therapeutics by FDA officials Janet Woodcock and Marta Wosinka.

View Full Article in:

Pharmalot.com

Published in Briefs: